Thromb Haemost 2021; 121(05): 625-640
DOI: 10.1055/s-0040-1720976
Stroke, Systemic or Venous Thromboembolism

Risk Factors for Central Venous Access Device-Related Thrombosis in Hospitalized Children: A Systematic Review and Meta-Analysis

Lingyun Tian
1   Xiangya Nursing School, Central South University, Changsha, China
2   School of Nursing, Anhui University of Chinese Medicine, Hefei, China
,
Wan Li
1   Xiangya Nursing School, Central South University, Changsha, China
,
Yanan Su
1   Xiangya Nursing School, Central South University, Changsha, China
,
Huimin Gao
1   Xiangya Nursing School, Central South University, Changsha, China
,
Qiuhong Yang
1   Xiangya Nursing School, Central South University, Changsha, China
,
Pan Lin
1   Xiangya Nursing School, Central South University, Changsha, China
,
Liqian Wang
1   Xiangya Nursing School, Central South University, Changsha, China
,
Jiaqi Zeng
1   Xiangya Nursing School, Central South University, Changsha, China
,
Yinglan Li
1   Xiangya Nursing School, Central South University, Changsha, China
3   School of Nursing, Xinjiang Medical University, Urumqi, China
› Author Affiliations
Funding This study was supported by grants from the Regional Science Fund of National Natural Science Foundation of China (No. 72064037), the Xiangya Clinical Big Data System Construction Project of Central South University (No. 2013096), and the Surface Project of Natural Science Fund of Xinjiang Uygur Autonomous Region (No. 2020D01C149).

Abstract

Objective To identify the potential associations of patient-, treatment-, and central venous access device (CVAD)-related factors with the CVAD-related thrombosis (CRT) risk in hospitalized children.

Methods A systematic search of PubMed, EMBASE, Web of Science, the Cochrane Library, China National Knowledge Infrastructure, Wanfang, and VIP database was conducted. RevMan 5.3 and Stata 12.0 statistical software were employed for data analysis.

Results In terms of patient-related factors, the patient history of thrombosis (odds ratio [OR] = 3.88, 95% confidence interval [CI]: 2.57–5.85), gastrointestinal/liver disease (OR = 1.85, 95% CI: 0.99–3.46), hematologic disease (OR = 1.45, 95% CI: 1.06–1.99), and cancer (OR = 1.58, 95% CI: 1.01–2.48) were correlated with an increased risk of CRT. In terms of treatment-related factors, parenteral nutrition (PN)/total PN (OR = 1.70, 95% CI: 1.21–2.39), hemodialysis (OR = 2.17, 95% CI: 1.34–3.51), extracorporeal membrane oxygenation (OR = 1.51, 95% CI: 1.31–1.71), and cardiac catheterization (OR = 3.92, 95% CI: 1.06–14.44) were associated with an increased CRT risk, while antibiotics (OR = 0.46, 95% CI: 0.32–0.68) was associated with a reduced CRT risk. In terms of the CVAD-related factors, CRT risk was more significantly increased by peripherally inserted central catheter than tunneled lines (OR = 1.81, 95% CI: 1.15–2.85) or totally implantable venous access port (OR = 2.81, 95% CI: 1.41–5.60). And subclavian vein catheterization significantly contributed to a lower CRT risk than femoral vein catheterization (OR = 0.36, 95% CI: 0.14–0.88). Besides, multiple catheter lines (OR = 4.06, 95% CI: 3.01–5.47), multiple catheter lumens (OR = 3.71, 95% CI: 1.99–6.92), central line-associated bloodstream infection (OR = 2.66, 95% CI: 1.15–6.16), and catheter malfunction (OR = 1.65, 95% CI: 1.07–2.54) were associated with an increased CRT risk.

Conclusion The exact identification of the effect of risk factors can boost the development of risk assessment tools with stratifying risks.

Authors' Contributions

L.T. was responsible for the design of retrieval strategies, the selection of articles, the extraction of data, the evaluation of evidence quality, the analysis and interpretation of data, the writing of the initial draft and the revision of the manuscript. W.L., Y.S., H.G., Q.Y., P.L., L.W., and J.Z. assisted in the selection of articles, data extraction, the evaluation of evidence quality, the interpretation of data, and the revision of the manuscript. Y.L. conceptualized and designed the systematic review, coordinated and supervised the review, and revised the manuscript. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.


Supplementary Material



Publication History

Received: 05 July 2020

Accepted: 23 September 2020

Article published online:
13 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thromb Res 2020; 187: 103-112
  • 2 Baumann Kreuziger L, Jaffray J, Carrier M. Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults. Thromb Res 2017; 157: 64-71
  • 3 Ullman AJ, Kleidon T, Gibson V. et al. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials. BMJ Open 2016; 6 (06) e011197
  • 4 Ruebner R, Keren R, Coffin S, Chu J, Horn D, Zaoutis TE. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics 2006; 117 (04) 1210-1215
  • 5 Kelly LJ, Snowden A, Paterson R, Campbell K. Health professionals' lack of knowledge of central venous access devices: the impact on patients. Br J Nurs 2019; 28 (14) S4-S14
  • 6 Ullman AJ, Cooke M, Kleidon T, Rickard CM. Road map for improvement: point prevalence audit and survey of central venous access devices in paediatric acute care. J Paediatr Child Health 2017; 53 (02) 123-130
  • 7 Beck O, Muensterer O, Hofmann S. et al. Central venous access devices (CVAD) in pediatric oncology patients-a single-center retrospective study over more than 9 years. Front Pediatr 2019; 7: 260
  • 8 Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of central venous access devices: a systematic review. Pediatrics 2015; 136 (05) e1331-e1344
  • 9 Kleidon TM, Rickard CM, Schults JA. et al. Development of a paediatric central venous access device database: a retrospective cohort study of practice evolution and risk factors for device failure. J Paediatr Child Health 2020; 56 (02) 289-297
  • 10 Ullman AJ, Kleidon T, Cooke M, Rickard CM. Substantial harm associated with failure of chronic paediatric central venous access devices. BMJ Case Rep 2017; 2017: bcr2016218757
  • 11 Rajasekhar A, Streiff MB. How I treat central venous access device-related upper extremity deep vein thrombosis. Blood 2017; 129 (20) 2727-2736
  • 12 Wang LL, Wang JR, Gao P, Wang YL, Wang XJ, Cui ZB. Diagnosis, prevention and treatment of central venous access device-related upper extremity deep vein thrombosis. Zhongguo Huxi Yu Weizhong Jianhu Zazhi 2018; 17 (05) 532-538
  • 13 Margulis AV, Pladevall M, Riera-Guardia N. et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clin Epidemiol 2014; 6: 359-368
  • 14 Jing W, Zhao S, Liu J, Liu M. ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ Open 2020; 10 (01) e034114
  • 15 Xiang AL, Zhang L, Ye FL. Application of general inverse variance method in meta-analysis. J Math Med 2012; 25 (01) 9-11
  • 16 Cornfield J. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst 1951; 11 (06) 1269-1275
  • 17 Kunutsor SK, Mäkikallio TH, Seidu S. et al. Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. Eur J Epidemiol 2020; 35 (05) 431-442
  • 18 Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: l-30
  • 19 Wang ZY, Weng H, Li BH, Ren XQ, Zeng XT. Application of RevMan 5.3 software for data transformation in etiological and prognostic meta-analysis. Chin J Evid Based Med 2017; 17 (07) 852-856
  • 20 Furlan AD, Pennick V, Bombardier C, van Tulder M. Editorial Board, Cochrane Back Review Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009; 34 (18) 1929-1941
  • 21 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21 (11) 1539-1558
  • 22 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629-634
  • 23 Jaffray J, Bauman M, Massicotte P. The impact of central venous catheters on pediatric venous thromboembolism. Front Pediatr 2017; 5: 5
  • 24 Vidal E, Sharathkumar A, Glover J, Faustino EV. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. J Thromb Haemost 2014; 12 (07) 1096-1109
  • 25 Neshat-Vahid S, Pierce R, Hersey D, Raffini LJ, Faustino EV. Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis. J Thromb Haemost 2016; 14 (09) 1749-1758
  • 26 Saber W, Moua T, Williams EC. et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011; 9 (02) 312-319
  • 27 Zhang TS, Zhong WZ, Li B. Applied Methodology for Evidence-Based Medicine. 2nd ed.. Hunan Province: Central South University Press; 2016
  • 28 Sun X, Gu J. Malignant hematopathy and thrombosis. J Clin Hematol 2011; 24 (05) 565-568
  • 29 Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009; 27 (29) 4834-4838
  • 30 Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101 (03) 439-451
  • 31 Vladareanu AM, Popov V, Bumbea H. et al. Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms. J Med Life 2011; 4 (01) 97-101
  • 32 Chen L, Yu B, Hou JB. Relationship between microparticles and coronary heart disease. Int J Cardiovasc Dis 2005; 5: 29-31
  • 33 Yang K. Malignant Tumor Associated Venous Thromboembolism Clinical Research of Related Factors. Shanxi Province: Shanxi Medical University; 2015
  • 34 Nylund CM, Goudie A, Garza JM, Crouch G, Denson LA. Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013; 56 (05) 485-491
  • 35 Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010; 375 (9715): 657-663
  • 36 Amin SC, Pappas C, Iyengar H, Maheshwari A. Short bowel syndrome in the NICU. Clin Perinatol 2013; 40 (01) 53-68
  • 37 Kakzanov V, Monagle P, Chan AK. Thromboembolism in infants and children with gastrointestinal failure receiving long-term parenteral nutrition. J Parenter Enteral Nutr 2008; 32 (01) 88-93
  • 38 Chen MH. The clinical value of color doppler ultrasound in monitoring the complications of arteriovenous internal fistula in patients with hemodialysis. Shanxi Med J 2017; 46 (02) 160-162
  • 39 Wei H, Wang JL, Yang YX. Correlation between serum irisin level and thrombosis of arteriovenous internal fistula in elderly maintenance hemodialysis patients. Zhongguo Laonianxue Zazhi 2019; 39 (22) 5553-5556
  • 40 Qiu CY. Analysis on the Dysfunction Incidence and Its Influencing Factors Indwelling Jugular Dialysis Tube with a Cuff. Guangdong Province: Jinan University; 2016
  • 41 Weber C, Deppe AC, Sabashnikov A. et al. Left ventricular thrombus formation in patients undergoing femoral veno-arterial extracorporeal membrane oxygenation. Perfusion 2018; 33 (04) 283-288
  • 42 Kuang XH, Zhang X, Gao XL. et al. Impact of anticoagulation on deep vein thrombosis occurrence in patients after right heart catheterization. Chin Circ J 2017; 32 (08) 776-779
  • 43 Jaffray J, Witmer C, O'Brien SH. et al. Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children. Blood 2020; 135 (03) 220-226
  • 44 Tran M, Shein SL, Ji X, Ahuja SP. Identification of a “VTE-rich” population in pediatrics - critically ill children with central venous catheters. Thromb Res 2018; 161: 73-77
  • 45 Onyeama SN, Hanson SJ, Dasgupta M, Baker K, Simpson PM, Punzalan RC. Central venous catheter-associated venous thromboembolism in children with hematologic malignancy. J Pediatr Hematol Oncol 2018; 40 (08) e519-e524
  • 46 Pikwer A, Åkeson J, Lindgren S. Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia 2012; 67 (01) 65-71
  • 47 Askegard-Giesmann JR, Caniano DA, Kenney BD. Rare but serious complications of central line insertion. Semin Pediatr Surg 2009; 18 (02) 73-83
  • 48 Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M. ESPEN. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009; 28 (04) 365-377
  • 49 Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev 2012; 2012 (03) CD004084
  • 50 Wu GX. Effect of early ankle pump exercise on preventing deep vein thrombosis after femoral vein catheterization in patients with liver cirrhosis. J Clin Nurs Pract 2018; 3 (01) 35
  • 51 Li JL, Yang M. Observation on the application of femoral vein catheterization in the treatment of tumor emergency. J Qiqihar Univ Med 2012; 33 (13) 1825
  • 52 Baskin JL, Pui CH, Reiss U. et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009; 374 (9684): 159-169
  • 53 Gnannt R, Waespe N, Temple M. et al. Increased risk of symptomatic upper-extremity venous thrombosis with multiple peripherally inserted central catheter insertions in pediatric patients. Pediatr Radiol 2018; 48 (07) 1013-1020
  • 54 Bicudo D, Batista R, Furtado GH, Sola A, Medeiros EA. Risk factors for catheter-related bloodstream infection: a prospective multicenter study in Brazilian intensive care units. Braz J Infect Dis 2011; 15 (04) 328-331
  • 55 Zeng XY. Analysis of High Risk Factors Associated with Catheter-Related Thrombosis in Children with Central Venous Catheterization. Zhejiang Province: Zhejiang University; 2019
  • 56 Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004; 9 (02) 207-216
  • 57 Mehall JR, Saltzman DA, Jackson RJ, Smith SD. Fibrin sheath enhances central venous catheter infection. Crit Care Med 2002; 30 (04) 908-912
  • 58 Ma LL. The Effects of Low Dose Aspirin on Hemorheology and Catheter Dysfunctions Related to Fibrin Sheaths of the Cancer Patients with PICC. Hunan Province: Central South University; 2014
  • 59 Li TG, Wang NN, Zhao M. Feasibility study of central vein catheterization under emergency bedside ultrasound guidance. Chin Crit Care Med 2015; 27 (09) 724-728